Company intelligence / Profile preview

Transpharmation

London, England, United Kingdomtranspharmation.com ↗

Ownership: Private
Development stage: Commercial

Overview

Transpharmation provides translational preclinical neuroscience research services using validated animal models to support drug discovery programs targeting central nervous system diseases. They are recognized for expertise in behavioral and biomarker research applied to psychiatric and neurodegenerative disorders. No clinical results of their own are reported as they are a CRO supporting client pipelines.

Recent developments include the acquisition of Saretius Ltd., expansion into Canada via rebranding of InterVivo Solutions as "Transpharmation Canada", and ongoing collaborations with global pharma/biotech clients.

Therapeutic areas: PsychiatryNeurology
Modalities: Small moleculeBiologic
Industry: Drug Discovery Services

Partnerships

Cykel AI partnership for talent acquisitionSaretius Ltd.

Beyond the preview

Go deeper on Transpharmation.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transpharmation.

Explore the full profile